Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor 5HT2C (5-hydroxytryptamine receptor 2C or HTR2C) is a G protein-coupled receptor (GPCR) that binds serotonin. It is expressed in the choroid plexus, hippocampus, amygdala, substantia nigra, and other brain regions, and is involved in mood, appetite, anxiety, temperature regulation, locomotion, and sexual function. It signals through Gq/G11 proteins, activating PLC and increasing intracellular Ca2+. Therapeutic interest includes obesity, psychiatric disorders, and substance use disorders. The receptor exists as a homodimer. Polymorphisms can have sex-specific effects due to X-chromosome localization.
Gq/G11 protein activation leading to PLC activation, IP3 production, and intracellular Ca2+ release; PLA2 activation; RhoA/PLD pathway activation; ERK signaling activation; Inhibition of dopamine and norepinephrine release.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5HT2C (5HT2C).